Resultados de la búsqueda 741-750 of 13876 for Stopping+bleeding

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. Numeración ...

  2. Centros vasculares - Ensayos clínicos - Mayo Clinic

    All participants who have not previously provided a blood sample will be given the option to provide a blood sample for genetic sequencing. A Study To ...

  3. Oncología (médica) - Ensayos clínicos

    ... blood samples) are predictors of treatment success. ... stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. A Study to ...

  7. Oncología (médica) - Ensayos clínicos

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... blood samples) are predictors of treatment success. ... stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...